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and Venkatesh Rangarajan1*Abstract
Metastatic involvement of the heart is a rare occurrence and remains undiagnosed until autopsy. In some instances,
patients may have cardiac symptoms, leading to ante-mortem diagnosis. Although most primary cancers have been
documented to metastasize to heart, the existing literature on cancers of upper aero-digestive tract is an exception,
with only a few reports. We report four cases of upper aero-digestive tract cancers, three of which arise from oral
cavity, one from lower esophagus, metastasising to the myocardium, detected on 18 F – Fluoro-deoxy-glucose
Positron Emission Tomography/Computed Tomography (FDG PET/CT) study , in the absence of related symptoms.
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Myocardial metastases have been reported from almost all
cancers, commonest of these being lung, breast and mel-
anoma primaries. Upper aero-digestive tract cancers have
shown extremely low incidence of metastases to heart; the
reasons being a lack of prospective imaging work-up and
absence of whole body imaging. Also, imaging work-up so
far was prompted only after the occurrence of symptoms;
thus the larger subset of asymptomatic patients was left
uninvestigated. We therefore report a series of four cases,
one being a primary from GE junction and three from
head neck region, wherein myocardial metastases were de-
tected on whole body FDG PET/CT imaging. These pa-
tients were referred for PET/CT imaging for established
indications; staging of esophageal cancer and restaging of
head neck cancers following a biopsy proven local site re-
currence. Thus, FDG PET/CT was obviously being done,
with the future plan of treatment in view, and hence de-
tection of myocardial metastases in all these four patients
had a significant impact on management, especially since
all were clinically asymptomatic. This work not only high-
lights the role of fusion imaging with PET/CT in picking* Correspondence: drvrangarajan@gmail.com
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ment, but also makes the clinicians aware of the possi-
bility of myocardial metastases from cancers of upper
aero-digestive tract.Case presentation
Case 1
A 53 year old male presented to our institution with pro-
gressive dysphagia since 2 months. Upper gastro-intestinal
endoscopy showed an ulcero-proliferative mass involving
the lower third of esophagus and gastro-esophageal junc-
tion (GEJ). Biopsy showed adenocarcinoma cells. Subse-
quently he underwent a whole body 18 F –FDG PET/CT
study for pre-operative staging. MIP image showed tracer
concentration at the primary site in lower esophagus and
GEJ (Figure 1A - arrow), and in upper abdominal nodes.
Focal tracer uptake was noted in cardiac region (1A -
arrowhead), which on axial CT (1B – arrow) and fused
PET/CT (1C – arrow) images was localized to the left ven-
tricular myocardium. This was initially thought to be
physiological FDG uptake in papillary muscle, hence 2-D
Echo was done for confirmation. 2-D Echo showed a mass
in the left ventricular myocardium (Figure 2 - arrow) con-
firming the presence of myocardial metastases. The man-
agement intent changed to palliative, hence no further
PET/CT imaging was done for follow up.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Myocardial metastases from esophageal cancer.
A- MIP image showing primary esophageal mass (arrow) with focal
uptake in region of heart (arrowhead), B- Hypodense lesion in left
ventricular myocardium (arrow) on axial CT images showing, C- FDG
uptake on axial fused PET/CT images (arrow).
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A 29 year old male, a tobacco chewer since 8 years, was
diagnosed with cancer of left buccal mucosa. He was
treated with chemo-radiation. 2 months after treatment
completion, follow up PET/CT was unremarkable. He
later presented with significant weight loss and clinicallyFigure 2 2-D Echo image showing mass in left ventricular
myocardium (arrow).palpable cervical nodes, after a disease free interval of 18
months. Biopsy revealed recurrent squamous cell cancer.
Whole body FDG PET/CT study was done for restaging.
MIP images showed multiple foci of uptake in neck region,
suggestive of local site recurrence and metastatic nodes
(Figure 3A). Also seen were metastatic foci in bones, liver
and other nodal regions. A discrete focal uptake in cardiac
region was seen as an FDG avid hypodense area on axial
fused PET/CT (3B –arrow) and CT (3C – arrow) images,
which was highly suspicious for metastases. 2-D Echo was
performed for cardiac status evaluation, before starting pal-
liative chemotherapy. It confirmed the presence of mass in
the left ventricular myocardium (Figure 4 - arrow). Patient
was not imaged further and eventually lost to follow-up.Case 3
A 32 year old female patient was a treated case of squa-
mous cancer of right lateral border of tongue. She under-
went wide excision and right lateral neck dissection,
followed by a disease free interval of 2 years. She then pre-
sented with a swelling over ala of the nose, biopsy of
which revealed metastatic squamous carcinoma from the
known primary. Whole body PET/CT done for restaging
showed focal uptake at the site of recurrence in neck
region (Figure 5A - arrow), with a metastatic lung lesion
(5A – bold arrow) and discrete intense tracer concentration
in the region of heart (5A – arrowhead). Axial CT (5B –
arrow) and fused PET/CT (5C – arrow) images showed a
large hypodense FDG avid mass in the left ventricularFigure 3 Myocardial metastases from buccal mucosal cancer.
A - MIP image showing multiple metastatic foci, B- Axial fused PET/CT
image showing tracer uptake in the cardiac region (arrow), which
corresponds to C -hypodense lesion on axial CT image (arrow).
Figure 4 2-D Echo image showing left ventricular myocardial
mass (arrow).
Figure 6 2-D Echo image showing large mass in left ventricular
myocardium (arrow).
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work-up showed a 17 mm sized mass in the left ventricu-
lar myocardium adjoining the inter-ventricular septum
(Figure 6 - arrow), confirming the presence of cardiac me-
tastases. Patient was on palliative chemotherapy, with fol-
low up CT scan at 3 months showing stable disease.Figure 5 Myocardial metastases from tongue cancer. A - MIP
image showing tracer uptake in left neck region (thin arrow), with
another large area in thorax (thick arrow). Focal uptake is noted in
cardiac region (arrow-head). B - large hypodense lesion in left
ventricular myocardium, C - FDG uptake in the myocardial mass.Case 4
A 46 year old gentleman, case of squamous cancer of right
vallecula, treated with chemo-radiation came for follow-up
at one year. Pan-endoscopy revealed suspicious thickening
in right vallecula and adjacent base of tongue. Biopsy re-
vealed squamous cells. Patient underwent a whole body
FDG PET/CT study for restaging. MIP images showed
tracer uptake in the right neck region (Figure 7A - arrow).
Discrete intense focus of FDG uptake was seen in the re-
gion of heart (Figure 7A - arrowhead). Axial fused PET/CT
images (Figure 7B - arrow) showed that the focus corre-
sponded to myocardium overlying the right ventricle,
adjacent to the inter-ventricular septum, appreciated
better on sagittal images (Figure 7D - arrow). Contrast en-
hanced axial (Figure 7C - arrow) and sagittal CT (Figure 7E
- arrow) images showed a hypodense area, corresponding
to the site of FDG uptake in the myocardium overlying
the right ventricle, thus confirming it to be metastasis. 2-
D Echo was confirmatory for a mass in right ventricular
myocardium. Since patient had distant metastases, surgery
was ruled out and he was started on palliative chemother-
apy. Patient was referred to a peripheral cancer centre for
logistic reasons and hence lost to follow up.
Discussion
Metastatic cancer involving the heart was first described
by Boneti in 1700; the diagnosis being made post-mortem
[1]. The first report of ante-mortem diagnosis was pub-
lished in 1913 [2]. Cardiac involvement from a metastatic
cancer can be by direct extension, by hematogenous or
lymphatic route or by intra-cavitary diffusion either by in-
ferior vena cava or by the pulmonary veins [3]. Lymphatic
spread tends to give rise to pericardial metastases, as seen
Figure 7 (Image for article illustration). A - MIP image showing tracer uptake in neck region (arrow) and focal uptake in the midline in chest
(arrow-head), B & C - hypodense lesion in right ventricular myocardium along the septum on axial CT (arrow) and fused PET/CT (arrow) image,
D & E - same lesion seen on sagittal CT (arrow) and fused PET/CT (arrow) image.
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whereas hematogenous spread leads to myocardial
metastases [4]. Due to their propensity for generalized
hematogenous spread, malignant melanomas frequently
metastasise to the heart [5]. Esophageal cancers metas-
tasise to the heart predominantly by lymphatics. Tumor
cells infiltrate the mediastinal lymph nodes, through
which they reach the epicardial and then the myocardial
lymphatic system [6]. However, all reports of esophageal
cancers with this spread pattern are of squamous cell
origin [7-11], unlike Case 1 where adenocarcinoma cells
were seen on histology. Rare occurrence of myocardial
metastases has been reported from primary head and
neck cancers. DeLoach and Haynes in 1953 discovered
on autopsy that one of the nine patients of primary ma-
lignancy of tongue had myocardial or pericardial in-
volvement [12]. Gassman et al. reviewed 4124 autopsies
of cancer patients, of which 126 had primary tongue tu-
mors. 2 (1.5%) of these patients with tongue primary
cancer had myocardial involvement [13]. To the best of
our knowledge, there are six reports in 7 patients, with
cardiac metastases from head and neck primary cancers;
6 of which were detected ante-mortem, one on autopsy;
[14-19]. The above report shows that primary carcin-
oma of tongue metastasizes to heart with some degree
of frequency, with no explanation for this, being offered
so far. Primary origin in vallecula, in Case 4, though a
new site of primary, its anatomical proximity to base
of tongue, should also be taken note of. In case 2, the
primary cancer is in the buccal mucosa, which is an
altogether unique location for head and neck primary
with myocardial metastases.Detection of cardiac metastases in most of the reports is
by Echocardiography or Cardiac Magnetic Resonance Im-
aging (MRI). Echocardiography, particularly 2D imaging,
is sensitive for detection of cardiac metastases [20]. 3 out
of the 4 cases in our series have an echocardiographic con-
firmation. FDG PET/CT with its ability for whole body fu-
sion imaging is used for detection of distant metastases in
most of the cancers, including esophageal cancers. Onco-
logical FDG PET/CT is performed with a fasting period of
6 hours, ensuring minimum myocardial FDG uptake
[21]. Hence, in case of cardiac metastases, the mechan-
ism of increased FDG uptake at that site is GLUT re-
ceptor over-expression, as in the primary site. Reports
of cardiac metastases on PET/CT are seen in melanoma
[22], Ewings tumor [23], renal cell carcinoma [24] and
breast cancer [25], to name a few, with no reports from
cancers of upper aero-digestive tract. FDG PET/CT is
routinely used for restaging of head and neck cancers
[26]. Also, since dual modality imaging is possible with
PET/CT, CT component of PET/CT has been used for
localization and confirmation of tracer uptake in myo-
cardium [27]. All existing reports of myocardial metas-
tases in head neck cancers are in patients who showed
local disease control and on follow up presented with
symptoms of chest pain, angina or syncopal episodes,
for which further evaluation was done, which led to de-
tection of cardiac metastases. Contrary to this, all pa-
tients in our series were asymptomatic. PET/CT studies
were done in these patients for restaging, due to clinical
suspicion of local recurrence; with the intent to rule out
distant metastases. In addition, 2-D Echocardiography was
done for confirmation of metastatic involvement (Case 1
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and 3), cardiac status evaluation was done as a part of
routine pre-chemotherapy work-up, which in retro-
spect, helped us confirm PET/CT imaging findings.
Cardiac involvement by metastatic malignancy is seen
exclusively in the setting of widespread metastatic dis-
ease; the recent autopsy series showing 5% of 2833 cadavers
having metastatic disease from malignant neoplasms with
myocardium being one of the sites [28]. Case 4 in our
series, showed local recurrence in vallecula, with an isolated
site of distant metastases in myocardium; in the absence
of nodal disease. This is an highly unusual phenomenon
which changed the intent of management from potentially
curative radical salvage to palliative care.
Cardiac metastases from upper aero-digestive tract can-
cers is thus an uncommon occurrence with majority of
cases detected on autopsy and otherwise, only a handful of
symptomatic patients were diagnosed on imaging by echo-
cardiography and most recently by cardiac MRI.
Conclusion
In conclusion, whole body dual modality imaging with PET/
CT in cancers of upper aero-digestive tract done for re-
staging can uncover such rare metastatic sites especially in
asymptomatic patients, which otherwise would have been
undiagnosed. It is a valuable addition to the existing litera-
ture on myocardial metastases, and also highlights the role
of FDG PET/CT in detection of such rare sites which can
very often have a significant impact on patient management.
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